Review Reports

Round 1

Reviewer 1 Report

The authors have presented in a clearly structured article the advantages of mass ORV of dogs based on a review of the current literature in India as well as on a risk analysis for a hypothetical ORV campaign  in dogs using hand distributiuon of oral rabies vaccine.

Remarks

in Table 1

Title

Strain or vaccine strain instead Vaccine

Vaccine name instead Band name

Lysvulpen vaccine is still used for ORV in Europe and the vaccine currently available on the market contains  mix of SAD Bern and SAD 19 like virus . This vaccine  is dedicated for vaccination of foxes and raccoon dogs

the name of the SAD B19 vaccine is Fuchsoral former manufacturer is IDT, Germany currently Ceva, France. Like Lysvulpen this vaccine is used for immunisation foxes and raccoon dogs in Europe

 

 

Author Response

Dear Reviewer 1,

Thank you very much for your thorough review and comments. 

1) We have made changes to the titles in the first 2 columns of Table 1 as suggested.

2) We have added SAD B19 “like" to vaccine strain details of Lysvulpen.

3) Thank you for the vaccine name "Fuchsoral". It has been added now.

Reviewer 2 Report

A very well written article on  an imprtant topic.

Modified Live
(3rd generation) SPBN GASGAS Rabitec® is already on the market , I think.

I highly recommend publishing this article.

Author Response

Dear Reviewer 2, 

Thank you very much for your review and comments. 

Yes, SPBN GASGAS Rabitec® is in the European market for the use in wildlife.